Full Text View
Tabular View
No Study Results Posted
Related Studies
Distant Healing for HIV/AIDS
This study has been completed.
Study NCT00079534   Information provided by National Center for Complementary and Alternative Medicine (NCCAM)
First Received: March 9, 2004   Last Updated: August 16, 2006   History of Changes

March 9, 2004
August 16, 2006
December 2000
 
 
 
Complete list of historical versions of study NCT00079534 on ClinicalTrials.gov Archive Site
 
 
 
Distant Healing for HIV/AIDS
Distant Healing Efforts for AIDS by Nurses and "Healers"

The purpose of this study is to determine whether individuals praying at a distance (also known as "Distant Healing") can positively affect the health of people with HIV/AIDS.

Significant numbers of people with HIV/AIDS seek spiritual or “psychic" treatment. Distant healing could potentially be of benefit to large numbers of HIV/AIDS patients, as it is widely available and requires no travel or other activity on the part of the patient. However, the treatment can be costly and has not yet been proven effective in a controlled clinical trial. This study will evaluate the efficacy of distant healing in patients with HIV/AIDS.

Participants in this study will be randomly assigned to either the distant healing group or a control group. All participants will have hour-long study visits at entry and Months 6 and 12. At study visits, participants will complete a demographic questionnaire, self-report health and symptom inventory, quality of life assessment, and profile of mood states. Blood will be drawn at each study visit.

 
Interventional
Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
  • HIV Infections
  • AIDS
Behavioral: Non-local/distant healing or prayer
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
150
December 2003
 

Inclusion criteria

  • HIV infection
  • History of a CD4 cell count less than 200 cells/mm3
  • Stable antiretroviral regimen
  • English-speaking

Exclusion criteria

  • Inability or unwillingness to fill out questionnaires
  • History of non-HIV related life-threatening disease
Both
18 Years to 65 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00079534
 
R01 AT000485-01
National Center for Complementary and Alternative Medicine (NCCAM)
 
Principal Investigator: Donald Abrams, MD University of California, San Francisco
Study Director: Jerome J. Stone, MA, RN California Pacific Medical Center
National Center for Complementary and Alternative Medicine (NCCAM)
August 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP